Analysis of samples with 100 protein panel.

The contract seeks to analyze biological samples to determine whether patterns of metabolites—both endogenous and exogenous—correlate with a predefined set of proteins established as predictors of cardiovascular disease risk. This research aims to uncover potential biomolecular relationships that could enhance early detection or risk stratification for cardiovascular conditions by linking metabolic profiles with known protein-based indicators. The study will focus on a panel of 100 specific proteins hypothesized to serve as predictive markers, requiring precise analytical methods to assess metabolite abundance and alignment with these protein signals. The posting is listed as a forecast by the Food and Drug Administration under NAICS code 541990, indicating it falls under other scientific research and development services. The opportunity is open for future procurement, with no solicitation number yet assigned and no set-aside designation specified. The point of contact for program inquiries is the Hfp Acquisition Liaison via hfpacquisitions@fda.hhs.gov, while the contracting officer details remain to be determined. The work is anticipated to be conducted without a specified physical location, and interested parties can find further information through the provided government portal.